AB153. Down-Regulated Expression of Excision of Repair Cross-Complementing Gene 1 Reduces Resistance to Hydroxycamptothecine in Bladder Cancer

Translational Andrology and Urology - China
doi 10.21037/tau.2016.s153
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Excision Repair Cross-Complementing Group 1 May Predict the Efficacy of Chemoradiation Therapy for Muscle-Invasive Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2010English

ERCC1 (Excision Repair Complementing Defective Repair in Chinese Hamster)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Prognostic Value of Excision Repair Cross-Complementation Group 1 Expression in Gastric Cancer: A Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

miR‑138‑5p Modulates the Expression of Excision Repair Cross‑complementing Proteins ERCC1 and ERCC4, and Regulates the Sensitivity of Gastric Cancer Cells to Cisplatin

Oncology Reports
MedicineCancer ResearchOncology
2018English

Excision Repair Cross-Complementing Group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin

Oncotarget
Oncology
2019English

Nucleotide Excision Repair Gene Polymorphisms and Recurrence After Treatment for Superficial Bladder Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Lack of Correlation Between X-Ray Repair Cross-Complementing Group 1 Gene Polymorphisms and the Susceptibility to Colorectal Cancer in a Malaysian Cohort

European Journal of Cancer Prevention
OncologyEpidemiologyCancer ResearchPublic HealthEnvironmentalOccupational Health
2017English

Fibulin-1 Is Epigenetically Down-Regulated and Related With Bladder Cancer Recurrence

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Expression of Excision Repair Cross-Complementation Group�1 and Class�III Β-Tubulin in Thymic Carcinoma

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy